SIVOTEC Inc.
Sivotec Bioinformatics is a company at the forefront of genomic innovation, developing AI-based bioinformatics solutions. Their flagship product, GENA™, is a commercial-grade Software-as-a-Service (SaaS) platform designed to revolutionize genomic analysis and diagnostics. GENA™ significantly shortens diagnosis time, from days to minutes, by leveraging Artificial Intelligence and Machine Learning to process complex genomic data. This accelerated analysis leads to improved workflow, higher quality results, and substantial cost savings per sample sequenced. The platform supports commercial labs, hospitals, and academic centers, enabling them to provide faster, more personalized healthcare. Sivotec is also the parent company of GENA, offering solutions like GENA Screen for AI-powered pre-diagnostic support, GENA Test for precision genetic testing, and GENA Fast Libraries for regulatory intelligence. Their mission is to accelerate the adoption of advanced genomic technologies by making genetic insights more accessible and actionable, ultimately improving patient outcomes and streamlining clinical decision-making.
SIVOTEC Inc.
Sivotec Bioinformatics is a company at the forefront of genomic innovation, developing AI-based bioinformatics solutions. Their flagship product, GENA™, is a commercial-grade Software-as-a-Service (SaaS) platform designed to revolutionize genomic analysis and diagnostics. GENA™ significantly shortens diagnosis time, from days to minutes, by leveraging Artificial Intelligence and Machine Learning to process complex genomic data. This accelerated analysis leads to improved workflow, higher quality results, and substantial cost savings per sample sequenced. The platform supports commercial labs, hospitals, and academic centers, enabling them to provide faster, more personalized healthcare. Sivotec is also the parent company of GENA, offering solutions like GENA Screen for AI-powered pre-diagnostic support, GENA Test for precision genetic testing, and GENA Fast Libraries for regulatory intelligence. Their mission is to accelerate the adoption of advanced genomic technologies by making genetic insights more accessible and actionable, ultimately improving patient outcomes and streamlining clinical decision-making.